Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | THPO | P40225 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.56 |
| ▸ | HRH1 | P35367 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29193534 | 0.87 | MEN1 (0.67) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL15667846 | 0.86 | MEN1 (0.54) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL7048157 | 0.85 | MEN1 (0.77) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL29069435 | 0.83 | MEN1 (0.56) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL235232 | 0.82 | MEN1 (0.64) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL5824225 | 0.82 | MEN1 (0.63) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL1643494 | 0.82 | MEN1 (0.63) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL9445136 | 0.82 | MEN1 (0.64) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL16513684 | 0.82 | MEN1 (0.49) | MEN1KMT2ACYP2C19RECQLMAPT | |
| SCHEMBL358543 | 0.82 | MEN1 (0.55) | MEN1KMT2ACYP2C19RECQLMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191845-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS Clínica de Diagnósticos Médicos Ltda (BR) | 2017-07-19 | — | — | EP | claimed |
| WO-2016038157-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS CLÍNICA DE DIAGNÓSTICOS MÉDICOS LTDA (BR) | 2016-03-17 | — | — | WO | claimed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | claimed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | claimed |
| US-20250282755-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2025-09-11 | — | — | US | disclosed |
| US-12338229-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | BAYLOR COLLEGE OF MEDICINE (US) | 2025-06-24 | — | — | US | disclosed |
| CN-120136844-A | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or revascularizing agents | 贝勒医学院 | 2025-06-13 | — | — | CN | disclosed |
| CN-112955217-B | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or revascularizing agents | 贝勒医学院 | 2025-04-08 | — | — | CN | disclosed |
| EP-3922990-B1 | SYSTEM FOR AUTOMATIC CHANGING AND SEALING OF DISPOSABLE CHROMATOGRAPHIC COLUMNS IN HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; MEASUREMENT METHOD AND ITS APPLICATION IN THE ANALYSIS OF BIOMARKER OF RARE DISEASE | MS EKSPERT SP Z O O (PL) | 2024-05-08 | — | — | EP | disclosed |
| US-20230357200-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2023-11-09 | — | — | US | disclosed |
| US-11708350-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | BAYLOR COLLEGE OF MEDICINE (US) | 2023-07-25 | — | — | US | disclosed |
| US-11493516-B2 | Biomarkers for assessing breast cancer | METABOLOMYCS, INC (US) | 2022-11-08 | — | — | US | disclosed |
| CN-108235734-A | Metabonomics profiling of central nervous system injury | 伦敦健康科学中心研究有限公司 | 2018-06-29 | — | — | CN | disclosed |
| US-20170299592-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | METABOLOMYCS, INC | 2017-10-19 | — | — | US | disclosed |
| EP-3191845-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS Clínica de Diagnósticos Médicos Ltda (BR) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016038157-A1 | BIOMARKERS FOR ASSESSING BREAST CANCER | IDCGS CLÍNICA DE DIAGNÓSTICOS MÉDICOS LTDA (BR) | 2016-03-17 | — | — | WO | disclosed |
| CN-102460160-B | For assessment of the neoformation label of kidney trouble | BIOCRATES LIFE SCIENCES AG (AT) | 2015-08-19 | — | — | CN | disclosed |
| CN-102460160-A | New biomarkers for assessing kidney diseases | BIOCRATES LIFE SCIENCES AG | 2012-05-16 | — | — | CN | disclosed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | disclosed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282755-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | NCOA3, FABP3, NCOA1 | MEN1 4718/4885KMT2A 4286/4885CYP2C19 4813/4885 |
| US-12338229-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | NCOA3, FABP3, NCOA1 | MEN1 4718/4885KMT2A 4286/4885CYP2C19 4813/4885 |
| US-11708350-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | NCOA3, FABP3, NCOA1 | MEN1 4718/4885KMT2A 4286/4885CYP2C19 4813/4885 |
| US-20230357200-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | NCOA3, FABP3, NCOA1 | MEN1 4718/4885KMT2A 4286/4885CYP2C19 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.